Only tablet type is available for Riluzole, and suspension type is expected to be an alternative for patients with difficulty in swallowing. According to industries on the 1st, SK Chemical's Teglutik Suspension was listed at 134,970 won per bottle.

Riluzole, the main ingredient of Teglutik, is used in the treatment of Amyotrophic Lateral Sclerosis (ALS), which is known to delay symptoms by several months. Riluzole is the first drug approved for Lou Gehrig's disease and is most commonly used. There are two products in Korea: Rilutek and Yooritek by Riluzole. Based on IQVIA in 2021, Rilutek showed sales of 3.7 billion won and Yuritech 2.5 billion won. Despite such identical products, Teglutik is introduci